全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
华西医学  2011 

两种骨质疏松自我评价工具应用于围绝经期和绝经后妇女的筛检效果比较

, PP. 656-659

Keywords: 骨密度,骨质疏松症,骨质疏松自我评价工具,筛检效果

Full-Text   Cite this paper   Add to My Lib

Abstract:

【】 目的 评价亚洲骨质疏松自我评价工具(OSTA)和我国妇女骨质疏松筛选工具(OSTC)与四川地区围绝经期和绝经后汉族妇女骨密度的关系,比较两种工具对骨质疏松症的筛检能力,探讨其临床应用价值。 方法 2010年7―10月筛选获得356名45岁以上妇女的双能X线骨密度仪腰椎、股骨颈和全髋骨密度数据,利用体重和年龄分别计算OSTA指数与OSTC指数,并进行比较。 结果 OSTA指数与OSTC指数和各部位骨密度值均呈正相关(r=0.458~0.593和r=0.440~0.599,P<0.001),两种筛选指数之间呈正相关(r=0.956,P<0.001)。按两级危险程度分类界值进行判定,OSTA和OSTC的灵敏度分别为78.2%、93.5%,特异度为67.2%、43.0%,受试者工作特征曲线下面积为0.792、0.798,Kappa系数为0.452、0.357。 结论 OSTA与OSTC应用于四川地区围绝经期和绝经后妇女骨质疏松症的筛查效果均不理想,临床应用价值受限。【Abstract】 Objective Toevaluatetherelationshipbetweenosteoporosisself-assessmenttoolforasians(OSTA),osteoporosisself-assessmenttoolforAsians(OSTC)andbonemineraldensityinSichuanperimenopausalandpostmenopausalwomenofHannationality,anddiscussthevalueoftheirclinicalapplicationthroughcomparisonofthescreeningabilityofthetwotoolsinpredictingosteoporosisandlowbonemass. Methods Withthedataofbonemineraldensityatlumbarspine,femoralneckandtotalproximalfemurmeasuredbyDXAof356womenaged45yearsoldandabove,OSTAandOSTCriskindexesofeachsubjectwerecalculatedbasedontheirweightandage,andwerethencompared. Results Thebonemineraldensityofabove-mentionedlocationswerepositivelycorrelatedwithOSTAandOSTCindexes(r=0.458-0.593andr=0.440-0.599,P<0.001),andthesetwoindexeswerealsocorrelatedpositively(r=0.956,P<0.001).Accordingtothetworisklevelsbythesecutoffs,OSTAandOSTCindexescoulddiagnoseosteoporosiswiththesensitivityof78.2%and93.5%,thespecificityof67.2%and43%,theareaunderROCcurveof0.792and0.798,andtheKappavalueof0.452and0.357,respectively. Conclusion BothOSTAandOSTCwerenotidealtoolsforscreeningosteoporosisinperimenopausalandpostmenopausalwomeninSichuanprovince.

References

[1]   Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry[J]. CMAJ, 2000, 162(9): 1289-1294.
[2]   Koh LK, Sedrine WB, Torralba TP, et al. A simple tool to identify Asian women at increased risk of osteoporosis[J]. Osteoporos Int, 2001, 12(8): 699-705.
[3]   Sedrine WB, Chevallier T, Zegels B, et al. Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry[J]. Gynecol Endocrinol, 2002, 16(3): 245-250.
[4]   Dennison E, Cole Z, Cooper C. Diagnosis and epidemiology of osteoporosis[J]. Curr Opin Rheumatol, 2005, 17(4): 456-461.
[5]   Lewiecki EM. Clinical application of bone density testing for osteoporosis[J]. Minerva Med, 2005, 96(5): 317-330.
[6]   Florent R, Frederic D, Olivier E, et al. Development and validation of the ORACLE seore to predict risk of osteoporsis[J]. Myao Clin Proc, 2004, 79(11): 1402-1408.
[7]   van Staa TP, Geusens P, Pols HA, et al. A simple clinical score for estimating the long-termrisk of fracture in patients using oral g1ucocorticoids[J]. QJM, 2005, 98(3): 191-198.
[8]   张菊英, 吴涛, 杨定焯, 等. 中国大陆地区妇女骨质疏松筛选工具探讨[J]. 中国修复重建外科杂志, 2007, 21(1): 86-89.
[9]   中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(讨论稿)[J]. 中华全科医师杂志, 2006, 5(8): 455-457.
[10]   陈德才, 张林, 徐梁, 等. 一家大型医院住院患者骨质疏松症诊治现状的初步调查[J]. 中华骨质疏松和骨矿盐疾病杂志, 2010, 3(1): 28-33.
[11]   Nguyen TV, Center JR, Pocock NA, et al. Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women[J]. Osteoporos Int, 2004, 15(1): 49-55.
[12]   Li-Yu JT, Llamado LJ, Torralba TP. Validation of OSTA among Filipinos[J]. Osteoporos Int, 2005, 16(12): 1789-1793.
[13]   Park HM, Sedrine WB, Reginster JY. Korean experience with the OSTA risk index for osteoporosis: a validation study[J]. J Clin Densitom Fall, 2003, 6(3): 247-250.
[14]   卢春燕, 蔡云华, 陈德才. OSTA筛选图表与双能X线吸收法诊断骨质疏松的一致性研究[J]. 骨质疏松和骨矿盐疾病基础与临床, 2004, 3(4): 207-212.
[15]   陈俊, 杨定焯, 张菊英, 等. 亚洲妇女骨质疏松自我评价工具应用于我国大陆地区绝经后妇女骨质疏松的筛检效果评价[J]. 中国慢性病预防与控制, 2009, 17(2): 142-144.
[16]   张浩, 章振林, 黄琪仁, 等. 两种骨质疏松筛选方法在绝经后骨质疏松妇女中的应用比较[J]. 中国骨质疏松杂志, 2009, 15(6): 395-399.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133